• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人芽囊原虫对甲硝唑的分离抗性。

Isolate resistance of Blastocystis hominis to metronidazole.

作者信息

Haresh K, Suresh K, Khairul Anus A, Saminathan S

机构信息

Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Trop Med Int Health. 1999 Apr;4(4):274-7. doi: 10.1046/j.1365-3156.1999.00398.x.

DOI:10.1046/j.1365-3156.1999.00398.x
PMID:10357863
Abstract

Isolates of Blastocystis hominis from infected immigrant workers from Indonesia, Bangladesh and infected individuals from Singapore and Malaysia were assessed for growth pattern and degree of resistance to different concentrations of metronidazole. Viability of the cells was assessed using eosin-brillian cresyl blue which stained viable cells green and nonviable cells red. The Bangladeshi and Singaporean isolates were nonviable even at the lowest concentration of 0.01 mg/ml, whereas 40% of the initial inoculum of parasites from the Indonesian isolate at day one were still viable in cultures with 1.0 mg/ml metronidazole. The study shows that isolates of B. hominis of different geographical origin have different levels of resistance to metronidazole. The search for more effective drugs to eliminate th parasite appears inevitable, especially since surviving parasites from metronidazole cultures show greater ability to multiply in subcultures than controls.

摘要

对来自印度尼西亚、孟加拉国的受感染移民工人以及来自新加坡和马来西亚的受感染个体的人芽囊原虫分离株进行了生长模式和对不同浓度甲硝唑耐药程度的评估。使用伊红-灿烂甲酚蓝评估细胞活力,该染料将活细胞染成绿色,死细胞染成红色。孟加拉国和新加坡的分离株即使在最低浓度0.01mg/ml时也无活力,而来自印度尼西亚分离株的初始接种寄生虫在第1天,有40%在含有1.0mg/ml甲硝唑的培养物中仍有活力。该研究表明,不同地理来源的人芽囊原虫分离株对甲硝唑具有不同程度的耐药性。寻找更有效的药物来消除这种寄生虫似乎是不可避免 的,特别是因为来自甲硝唑培养物中的存活寄生虫在传代培养中比对照显示出更强的增殖能力。

相似文献

1
Isolate resistance of Blastocystis hominis to metronidazole.人芽囊原虫对甲硝唑的分离抗性。
Trop Med Int Health. 1999 Apr;4(4):274-7. doi: 10.1046/j.1365-3156.1999.00398.x.
2
Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole.人芽囊原虫以及甲硝唑和甲氧苄啶/磺胺甲恶唑的疗效评估
Parasitol Res. 2005 Jun;96(4):273-5. doi: 10.1007/s00436-005-1363-1. Epub 2005 May 25.
3
Polypeptides associated with in vitro cyst formation of Blastocystis hominis.与人类芽囊原虫体外包囊形成相关的多肽。
Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):727-32.
4
In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome.从肠易激综合征患者分离出的人芽囊原虫的体外药敏性。
Br J Biomed Sci. 2004;61(2):75-7. doi: 10.1080/09674845.2004.11732647.
5
Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review.甲硝唑对有症状患者中溶组织内阿米巴的根除效果不佳:病例系列及系统文献综述
Gastroenterol Hepatol. 2017 Jun-Jul;40(6):381-387. doi: 10.1016/j.gastrohep.2016.11.003. Epub 2017 Mar 6.
6
Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.布拉氏酵母菌或甲硝唑治疗症状性人芽囊原虫感染儿童的临床疗效。
Parasitol Res. 2011 Mar;108(3):541-5. doi: 10.1007/s00436-010-2095-4. Epub 2010 Oct 5.
7
Pathogenicity of Blastocystis hominis, a clinical reevaluation.人芽囊原虫的致病性:一项临床重新评估
Turkiye Parazitol Derg. 2007;31(3):184-7.
8
Resistance of Blastocystis hominis cysts to metronidazole.人芽囊原虫包囊对甲硝唑的耐药性。
Trop Med Int Health. 1996 Oct;1(5):677-8. doi: 10.1111/j.1365-3156.1996.tb00094.x.
9
In vitro Effect of Silver Nanoparticles on .体外银纳米粒子对. 的影响。
Int J Nanomedicine. 2020 Oct 22;15:8167-8173. doi: 10.2147/IJN.S272532. eCollection 2020.
10
IN VIVO AND IN VITRO EFFICACY OF NIGELLA SATIVA AQUEOUS EXTRACT ON BLASTOCYSTIS HOMINIS.黑种草水提取物对人芽囊原虫的体内和体外疗效
J Egypt Soc Parasitol. 2016 Apr;46(1):27-34. doi: 10.12816/0026147.

引用本文的文献

1
spp. Infection in Kidney Transplant Recipient.肾移植受者中的特定种感染。
Pathogens. 2025 Apr 1;14(4):341. doi: 10.3390/pathogens14040341.
2
The Role of spp. in the Etiology of Gastrointestinal and Autoimmune Diseases.某些物种在胃肠道疾病和自身免疫性疾病病因学中的作用。 (注:原文本中“spp.”表述有误,推测可能是“species”,这里按照纠正后的理解翻译。)
Pathogens. 2025 Mar 25;14(4):313. doi: 10.3390/pathogens14040313.
3
A mitochondrial carrier transports glycolytic intermediates to link cytosolic and mitochondrial glycolysis in the human gut parasite .
一种线粒体载体将糖酵解中间产物转运到人体肠道寄生虫的细胞质和线粒体糖酵解中,将二者联系起来。
Elife. 2024 May 23;13:RP94187. doi: 10.7554/eLife.94187.
4
Lipid Accumulation in Increases Cell Damage in Co-Cultured Cells.脂质积累增加共培养细胞中的细胞损伤。
Microorganisms. 2023 Jun 14;11(6):1582. doi: 10.3390/microorganisms11061582.
5
Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.在精神分裂症患者中观察到较高的阿米巴和甲硝唑耐药形式的芽囊原虫。
Parasit Vectors. 2022 Sep 5;15(1):313. doi: 10.1186/s13071-022-05418-0.
6
Anti-blastocystosis activity of antioxidant coated ZIF-8 combined with mesoporous silicas MCM-41 and KIT-6.抗氧化剂包覆的ZIF-8与介孔二氧化硅MCM-41和KIT-6联合使用的抗胚泡病活性
Sci Rep. 2022 Apr 17;12(1):6403. doi: 10.1038/s41598-022-10397-4.
7
Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.芽囊原虫和艰难梭菌:在强调溃疡性结肠炎的 IBD 患者中定植的协同作用证据。
Turk J Gastroenterol. 2021 Jun;32(6):500-507. doi: 10.5152/tjg.2021.19644.
8
In vitro susceptibility of human subtypes to simeprevir.人亚型对西米普明的体外敏感性。
Saudi J Biol Sci. 2021 Apr;28(4):2491-2501. doi: 10.1016/j.sjbs.2021.01.050. Epub 2021 Feb 2.
9
Antiprotozoal potential of against three virulent subtypes of sp.针对三种毒力亚型的 sp.的抗原生动物潜力
J Parasit Dis. 2020 Dec;44(4):694-701. doi: 10.1007/s12639-020-01247-z. Epub 2020 Jul 27.
10
The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on ST3.益生菌和导致机会性感染的人体肠道微生物对ST3的影响。
Gut Pathog. 2019 Feb 14;11:6. doi: 10.1186/s13099-019-0287-8. eCollection 2019.